secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYPHERPUNK TECHNOLOGIES INC. (CYPH)
CIK:        0001509745
Form:       8-K
Filed at:   2022-11-07T23:59:59+00:00
Accession:  0001104659-22-114996
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Leap Therapeutics receives Nasdaq bid price deficiency letter; has until May 1, 2023 to regain compliance
--------------------------------------------------------------------------------

- Closing bid price below $1.00 for 30 consecutive business days triggered Nasdaq deficiency notice.
- Company has 180 days (until May 1, 2023) to regain compliance by closing at $1.00 for 10 consecutive days.
- If not compliant by May 1, may be eligible for an additional 180-day period subject to other listing standards.
- Failure to cure could result in delisting; company may appeal to Nasdaq Hearings Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1509745/000110465922114996/0001104659-22-114996-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1509745/000110465922114996/tm2229684d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-114996

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer